Trials / Unknown
UnknownNCT05072275
Prospective Electronic Polygenic Risk Study
Prospective Electronic Polygenic Risk Study (PEPRS) - First Phase
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Scripps Translational Science Institute · Academic / Other
- Sex
- All
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the role of polygenic risk scores (PRS) in preventive health.
Detailed description
This study will investigate the role of polygenic risk scores (PRS) in preventive health. Specifically, the purpose of this study is to determine whether knowledge of the degree of coronary artery disease (CAD) genetic risk, as measured and conveyed by a PRS, influences patient and physician decision-making during short-term (6 month) and long-term (2 year) follow-up. The initial findings of this study will be used to plan an expanded second phase study with the purpose of prospectively validating that these decision-making changes lead to improvements in clinical outcomes.
Conditions
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-11-01
- Completion
- 2023-11-01
- First posted
- 2021-10-08
- Last updated
- 2022-11-07
Source: ClinicalTrials.gov record NCT05072275. Inclusion in this directory is not an endorsement.